Cubital tunnel syndrome is a peripheral medical condition of numbness, weakness, or tingling due to compression of the ulnar nerve. Cubital tunnel is located in the elbow and also known as ulnar neuropathy. Ulnar nerve is responsible for sensation and movement to the arm and hand. It supplies impulses to the back of the arm, around the inside of the elbow, neck to shoulder and hand in the fourth and fifth fingers. Excess pressure in the ulnar nerve causes swelling. Increased pressure from bone or connective tissue or nerve in the wrist, arm, or elbow. Numbness and pain in the elbow, tingling, especially in the little and ring fingers are early symptoms of cubital tunnel syndrome (CBTS). Decrease in the overall hand grip, claw-like deformity of the hand, weakness affecting the little and ring fingers, muscle wasting in the hand, and decrease in the ability to pinch the little finger and thumb are severe symptoms of cubital tunnel syndrome (CBTS). Some other frequent conditions associated or linked with the syndrome are thyroid dysfunction, high blood pressure, diabetes, and autoimmune disorders such as rheumatoid arthritis. Health care specialists recommend nerve conduction studies, physical examination, and other tests such as electromyography (EMG) to confirm cubital tunnel syndrome. According to the National Institute for Occupational Safety and Health (NIOSH), incidence of cubital tunnel syndrome is approximately 25 cases per 100 000 persons per year.
Increase in research and development, introduction of novel disease therapies, rise in demand for effective therapies among patients, and surge in disease prevalence are projected to fuel the growth of the global cubital tunnel syndrome treatment market. Lifestyle factors such as smoking, high body mass index (BMI), sedentary lifestyle, and high salt intake increases the risk for cubital tunnel syndrome. Increase in health care insurance coverage is the other factor likely to accelerate the growth of the market. The global cubital tunnel syndrome treatment market can be segmented based on treatment type, end-user, and region. In terms of treatment type, the market can be categorized into medications, physical and integrative therapies, and surgery. Based on end-user, the global cubital tunnel syndrome market can be classified into hospitals, clinics, and ambulatory surgical centers. In terms of revenue, the hospitals segment dominated the global cubital tunnel syndrome treatment market in 2016.
Geographically, the global cubital tunnel syndrome treatment market can be segmented into five major regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is the leading market for cubital tunnel syndrome treatment. In terms of revenue, the U.S. holds a major share of the market in North America. The market in Europe is expanding rapidly due to high prevalence of cubital tunnel syndrome. The market in Asia Pacific and Latin America is projected to expand significantly in the near future. Developing economies such as China and India are anticipated to contribute to the growth of the market in Asia Pacific between 2017 and 2025 due to better health care infrastructure, economic growth, increase in the number of insurance payers, growth of the private health care sector, and rise in awareness among the people. Brazil and Mexico dominate the cubital tunnel syndrome treatment market in Latin America. South Africa, Turkey, and other developing countries in Middle East & Africa contribute to market growth in MEA.
Key players operating in the global cubital tunnel syndrome treatment market include Eli Lily and Company, Pfizer, Inc., GlaxoSmithKline plc, Novartis AG, Bristol-Myers Squibb and Company, Amgen, Inc., Teva Pharmaceutical Industries Ltd., Johnson & Johnson, Sanofi, and Baxter Healthcare Corporation.
This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.
Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:
- Customer Experience Maps
- Insights and Tools based on data-driven research
- Actionable Results to meet all the business priorities
- Strategic Frameworks to boost the growth journey
The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.
The following regional segments are covered comprehensively:
- North America
- Asia Pacific
- Latin America
- The Middle East and Africa
The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.
Below is a snapshot of these quadrants.
1. Customer Experience Map
The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.
2. Insights and Tools
The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.
3. Actionable Results
The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.
4. Strategic Frameworks
The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.
The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:
1. What can be the best investment choices for venturing into new product and service lines?
2. What value propositions should businesses aim at while making new research and development funding?
3. Which regulations will be most helpful for stakeholders to boost their supply chain network?
4. Which regions might see the demand maturing in certain segments in near future?
5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?
6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?
7. Which government regulations might challenge the status of key regional markets?
8. How will the emerging political and economic scenario affect opportunities in key growth areas?
9. What are some of the value-grab opportunities in various segments?
10. What will be the barrier to entry for new players in the market?
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.